Search
SW033291
go.drugbank.com/drugs/DB32765Experimental[A275473, A275474] It has been found to increase prostaglandin E2 (PGE2) and is being investigated in accelerating of hematopoietic recovery and treating type 2 diabetes mellitus.[A275473, A275474] … SW033291 is a small molecule 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitor.
CB-010
go.drugbank.com/drugs/DB17711InvestigationalCB-010 is a CRISPR-edited allogeneic CAR-T cell therapy targeting CD19. It is being investigated for the treatment of follicular lymphoma.[L46158]
Bindarit
go.drugbank.com/drugs/DB12739InvestigationalBindarit has been used in trials studying the prevention and treatment of Coronary Restenosis and Diabetic Nephropathy.
DTP-348
go.drugbank.com/drugs/DB12741InvestigationalDtp348 has been used in trials studying the treatment of Solid Tumors and Head and Neck Neoplasms.
JLK-247
go.drugbank.com/drugs/DB17637ExperimentalJLK-247 is an adeno-associated viral vector serotype 9 (AAV9)-mediated gene replacement therapy for the treatment of Sanfilippo Syndrome Type C or MPS IIIC.[L46686]
Lorvotuzumab mertansine
go.drugbank.com/drugs/DB12089InvestigationalLorvotuzumab mertansine has been used in trials studying the treatment of SCLC, Leukemia, Ovarian Cancer, Multiple Myeloma, and Merkel Cell Carcinoma, among others.
Categories: Amino Acids, Peptides, and ProteinsIodoxamic acid
go.drugbank.com/drugs/DB13539ExperimentalRadiopaque medium used in the diagnosis of gall bladder & bile duct diseases, usually as meglumine salt.
Categories: Compounds used in a research, industrial, or household settingCevipabulin
go.drugbank.com/drugs/DB12533InvestigationalCevipabulin has been used in trials studying the treatment and educational/counseling/training of Tumors and Neoplasms.
Sodium cation
go.drugbank.com/drugs/DB14516InvestigationalSynonyms: Sodium ion, Sodium (ion)Mixtures: VAMIN 14 IV AMINOASIT SOLÜSYONU, 500 ML, NUTRIFLEX LIPID PERI INFUZYONLUK IV EMULSIYON, 2500 MLMG98
go.drugbank.com/drugs/DB06544ExperimentalMG98, a second-generation antisense oligodeoxynucleotide inhibitor of human DNMT1, was investigated in the completed clinical trial NCT00003890 for treating patients with advanced solid tumors.